Join to View Full Profile
1 S Park StMadison, WI 53715
Phone+1 608-287-2552
Fax+1 608-263-9830
Dr. Rajguru is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board-certified hematologist and oncologist with both a clinical expertise and research interest in lymphoma and CLL. I have written several clinical reviews on mantle cell lymphoma and have participated in numerous multi-institutional retrospective reviews on various topics including outcomes in double-hit lymphomas. I am currently on the NCCN panel for T-cell lymphomas and cutaneous B-cell lymphomas. I am also the current head of clinical research at the University of Wisconsin Carbone Cancer Center 1 S. Park Clinic in Madison, WI.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2012 - 2015- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2009 - 2012
University of Illinois College of MedicineClass of 2009
Certifications & Licensure
WI State Medical License 2011 - 2025
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsA Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer.Sailaja Kamaraju, Amy M Fowler, Sergey Tarima, Lubna N Chaudhary, Mark E Burkard
Clinical Breast Cancer. 2025-04-01 - Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphom...Julie E Chang, Danielle McQuinn, Meredith Hyun, KyungMann Kim, Vaishalee P Kenkre
Clinical Lymphoma, Myeloma & Leukemia. 2025-03-01 - Maintenance low-dose fixed duration lenalidomide and rituximab following bendamustine and rituximab induction in previously untreated chronic lymphocytic leukemia and ...Julie E Chang, Tuo Wang, KyungMann Kim, Matthew Folstad, Mariah Endres
Leukemia & Lymphoma. 2024-10-01
Press Mentions
She Was Training for a Marathon. Suddenly, She Could Barely WalkSeptember 30th, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
